N1876
Neomycin trisulfate salt hydrate
powder
Manufacturer: Sigma Aldrich
CAS Number: 1405-10-3
Synonym(S): Framycetin sulfate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 G | N1876-25-G | In Stock | ₹ 5,401.68 |
| 100 G | N1876-100-G | In Stock | ₹ 14,722.00 |
N1876 - 25 G
In Stock
Quantity
1
Base Price: ₹ 5,401.68
GST (18%): ₹ 972.302
Total Price: ₹ 6,373.982
form
powder
Quality Level
200
antibiotic activity spectrum
Gram-negative bacteriaGram-positive bacteria
Mode of action
protein synthesis | interferes
SMILES string
O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](O[C@@H]2CO)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)C(N)[C@@H](O)[C@@H]1O
InChI
1S/C23H46N6O13.3H2O4S.H2O/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;3*1-5(2,3)4;/h5-23,30-36H,1-4,24-29H2;3*(H2,1,2,3,4);1H2/t5-,6+,7-,8+,9-,10-,11?,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;;;;/m1..../s1
InChI key
WHAGUNPVKDUVFV-QGTTWHFQSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | TOKU-E Neomycin Sulfate, USP, 1405-10-3, 25 g | TOKU-E | ₹ 4,894.03 | |
 | TOKU-E Neomycin Sulfate, USP, 1405-10-3, 100 g | TOKU-E | ₹ 9,240.48 | |
 | TOKU-E Neomycin Sulfate, USP, 1405-10-3, 500 g | TOKU-E | ₹ 39,956.52 | |
 | Sigma Aldrich Fine Chemicals Biosciences Neomycin sulphate European Pharmacopoeia (EP) Reference Standard | 1405-10-3 | | Sigma Aldrich Fine Chemicals Biosciences | ₹ 23,582.90 | |
 | Enzo Life Sciences Neomycin . sulfate (25g). CAS: 1405-10-3 | Enzo Life Sciences | ₹ 44,474.09 | |
| | Neomycin sulfate | Sigma Aldrich | ₹ 47,987.23 | |
| | Neomycin sulfate, for microbiological assay | Sigma Aldrich | ₹ 16,107.60 | |
 | Neomycin trisulfate salt hydrate | Supelco | ₹ 2,673.78 | |
| | Neomycin trisulfate salt hydrate | Sigma Aldrich | ₹ 28,274.90 | |
| | Neomycin trisulfate salt hydrate | Sigma Aldrich | ₹ 3,734.63 - ₹ 23,230.45 |
Related Products
Description
- General description: Chemical structure: aminoglycoside
- Application: Neomycin Trisulfate is produced by Streptomyces containing a minimum of 85% neomycin B. It has been used as a selection agent for prokaryotic cells that have been transformed using the selectable marker gene (neo), and to study ototoxic side effects of antibiotics, platelet-derived growth factor responses in certain fibroblasts, and extraction of Nuclear Phosphatidylinositol 4,5-Bisphosphate-Interacting Proteins.[1][2][3].
- Biochem/physiol Actions: Mode of action: This product acts by binding to the 30S and 50S subunits, causing miscoding and inhibiting initiation and elongation during protein synthesis. Neomycin also blocks voltage-sensitive Ca2+ channels without affecting the Na+/Ca2+ antiporter in neurons.Antimicrobial spectrum: Neomycin acts against both gram-positive and gram-negative bacteria.
- Other Notes: Keep container tightly closed in a dry and well-ventilated place.Keep in a dry place
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Compare Similar Items
Show Difference
form: powder
Quality Level: 200
antibiotic activity spectrum: Gram-negative bacteriaGram-positive bacteria
Mode of action: protein synthesis | interferes
SMILES string: O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](O[C@@H]2CO)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)C(N)[C@@H](O)[C@@H]1O
InChI: 1S/C23H46N6O13.3H2O4S.H2O/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;3*1-5(2,3)4;/h5-23,30-36H,1-4,24-29H2;3*(H2,1,2,3,4);1H2/t5-,6+,7-,8+,9-,10-,11?,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;;;;/m1..../s1
InChI key: WHAGUNPVKDUVFV-QGTTWHFQSA-N
form:
powder
Quality Level:
200
antibiotic activity spectrum:
Gram-negative bacteriaGram-positive bacteria
Mode of action:
protein synthesis | interferes
SMILES string:
O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](O[C@@H]2CO)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)C(N)[C@@H](O)[C@@H]1O
InChI:
1S/C23H46N6O13.3H2O4S.H2O/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;3*1-5(2,3)4;/h5-23,30-36H,1-4,24-29H2;3*(H2,1,2,3,4);1H2/t5-,6+,7-,8+,9-,10-,11?,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;;;;/m1..../s1
InChI key:
WHAGUNPVKDUVFV-QGTTWHFQSA-N
form: powder
Quality Level: 200
antibiotic activity spectrum: __
Mode of action: __
SMILES string: COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)cc3O2
InChI: 1S/C28H34O15/c1-10-21(33)23(35)25(37)27(39-10)43-26-24(36)22(34)19(9-29)42-28(26)40-12-6-14(31)20-15(32)8-17(41-18(20)7-12)11-3-4-16(38-2)13(30)5-11/h3-7,10,17,19,21-31,33-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27-,28+/m0/s1
InChI key: __
form:
powder
Quality Level:
200
antibiotic activity spectrum:
__
Mode of action:
__
SMILES string:
COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)cc3O2
InChI:
1S/C28H34O15/c1-10-21(33)23(35)25(37)27(39-10)43-26-24(36)22(34)19(9-29)42-28(26)40-12-6-14(31)20-15(32)8-17(41-18(20)7-12)11-3-4-16(38-2)13(30)5-11/h3-7,10,17,19,21-31,33-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27-,28+/m0/s1
InChI key:
__
form: tablet
Quality Level: 200
antibiotic activity spectrum: __
Mode of action: __
SMILES string: __
InChI: __
InChI key: __
form:
tablet
Quality Level:
200
antibiotic activity spectrum:
__
Mode of action:
__
SMILES string:
__
InChI:
__
InChI key:
__
form: __
Quality Level: 100
antibiotic activity spectrum: __
Mode of action: __
SMILES string: CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12
InChI: 1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1
InChI key: VWPOSFSPZNDTMJ-UCWKZMIHSA-N
form:
__
Quality Level:
100
antibiotic activity spectrum:
__
Mode of action:
__
SMILES string:
CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12
InChI:
1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1
InChI key:
VWPOSFSPZNDTMJ-UCWKZMIHSA-N